ANI Pharmaceuticals (NASDAQ:ANIP) just reported results for the second quarter of 2024.
- ANI Pharmaceuticals reported earnings per share of $1.02. This was above the analyst estimate for EPS of 94 cents.
- The company reported revenue of $138.04 million.
- This was 7.32% better than the analyst estimate for revenue of $128.62 million.